Article Text

Download PDFPDF
Review: the cost-effectiveness of interventions for HIV/AIDS in Africa varies greatly

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 QUESTION: What is the cost effectiveness of HIV/AIDS interventions in Africa?

Data sources

Studies were identified by searching Medline, Popline, and EconLit (all from 1984–2000). Bibliographies of relevant articles were reviewed and experts in HIV/AIDS research contacted for unpublished studies.

Study selection

Studies were selected if they reported data for Africa, measured both cost and effectiveness, used standard methods for estimating costs and outcomes, included all major cost items, and allowed a generic measure of outcome (either HIV infections prevented or disability adjusted life years [DALYs] gained) to be calculated. Studies were excluded if the regimen was now out of date, drug prices had changed substantially, or the effectiveness of the intervention had been estimated before the results of clinical trials. Interventions not covered by the initial study selection criteria were included if some cost and effectiveness data existed or the drug costs were available. …

View Full Text

Footnotes

  • Source of funding: no external funding.

  • For correspondence: Mr A Creese, WHO, Geneva, Switzerland. creesea{at}who.ch